This webinar will give a summary of recently published ESTRO & ASTRO practice guidelines about radiotherapy for lung cancer in the COVID-19 pandemic, whether radiotherapy can or should be adapted, and if so how should this be done. We will address questions about whether radiotherapy can be delayed, fractionation of radiotherapy, multimodality treatment strategies and handling of COVID-19 positive patients. Considering a pandemic scenario characterized by a shortage of radiotherapy resources, we will discuss factors influencing patient prioritization and triage. These questions will be addressed in the format of six clinical cases with curative or palliative treatment for NSCLC and SCLC.
Format: The program will have the following format: Sequential discussion of 6 cases presented in ASTRO-ESTRO practice guideline, with Q & A after each case.